Patient P-03030
Therapy response
Stable
Tolerance
Deteriorating
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
82%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S14
- Day 39 NP-02 recommended — Dietary Support Protocol NP-02
- Day 40 Patient accepted — Started NP-02 in the companion
- Day 50 GI symptom burden −21% vs expected — Dietary Support Protocol NP-02
- Day 56 Tolerance state changed — Unstable → Improving
- Day 64 GI-04 recommended — GI Support Protocol GI-04
- Day 65 Patient accepted — Started GI-04 in the companion
- Day 69 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 73 No meaningful change — GI Support Protocol GI-04
What changed?
Trajectory began diverging from predicted response on Day 69.
Primary contributors, last 14 days
- Toxicity+18
- Inflammatory activity+11
- GI instability+3
- Nutritional resilience-3
- Treatment adherence-3
What helped?
- Dietary Support Protocol NP-02Day 39Result: symptom burden −21%
- GI Support Protocol GI-04Day 64Result: no meaningful change
LIFE OS recommendation
Supportive Compound SC-12
83%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 88% showed improvement
- median effect visible after 6 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log2.7/10
stable · -0.1 vs previous 14 d
Stress level
Daily log7/10
worsening · +0.3 vs previous 14 d
Pessimism score
Daily log6.7/10
stable · +0.2 vs previous 14 d
Sleep quality
Wearable19.2/100
stable · -0.4 vs previous 14 d
Libido
Daily log2.8/10
worsening · -0.2 vs previous 14 d
HRV
Wearable15 ms
worsening · -2.0 vs previous 14 d
Toxicity
Blood50.7/100
stable · -0.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 20 from the failing basin, 72 from restoration.
Would help
- ME-01 Monitoring Escalation100% improved among 11 similar · onset 3 d · confidence 81%
- SC-12 Supportive Compound89% improved among 9 similar · onset 6 d · confidence 81%
- DT-01 Dosing / Timing Recommendation63% improved among 8 similar · onset 5 d · confidence 81%
- More proteinGI -4.4 next day on high-intake days · n 21
Would not help
- GI-04 GI Support Protocolalready tried, no meaningful change
- AD-05 Adherence Supportonly 27% improved among 11 similar
- Keep histamine lowGI +3.9 next day on high-intake days · n 24
- Keep fat lowGI +3.2 next day on high-intake days · n 27
- Keep lactose lowGI +3.2 next day on high-intake days · n 22
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-4.4supporter · 95%
- Histamine load+3.9detractor · 95%
- Dietary fat load+3.2detractor · 95%
- Lactose+3.2detractor · 95%
- Caffeine-0.2no signal · 15%
- Alcohol0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓80
- MicrobiomeButyrate capacity 44/100
- MicrobiomeF. prausnitzii depleted
- Daily logFibre intake low in recent food logs
- Autonomic recovery ↓65
- WearableResting HR 77 bpm
- Wearable300 steps/day
- WearableShort sleep window
- Inflammatory signalling ↑60
- MicrobiomeBacteroides fragilis expansion
- BloodInflammatory load index 62
- WearableHRV 15 ms, trending down
- Mucosal barrier integrity ↓50
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Daily logGI symptom score 66 and rising
- Drug metabolism and exposure ↑20
- BloodToxicity index 51
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.1 · butyrate capacity 44/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 17 ms
- Sleep
- 6.0 h
- Steps
- 712
- Resting HR
- 74 bpm
Daily log: GI score 66, nutritional resilience 34, adherence 42.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.